PGC1A regulates the IRS1:IRS2 ratio during fasting to influence hepatic metabolism downstream of insulin
Open accessThe DOI matches its Crossref record; 46 of the 46 references it cites were found in a registry or an index.
Abstract
Significance: The liver plays crucial roles in the control of glucose homeostasis during the fast-feeding cycle. It responds to insulin and glucagon to either store or provide glucose to other organs. Insulin resistance is a hallmark of metabolic diseases such as type 2 diabetes and nonalcoholic fatty liver disease. Associations have been made between low hepatic levels of peroxisome proliferator-activated receptor gamma coactivator 1-alpha (PGC1A) and hepatic insulin resistance, but underlying mechanisms are elusive. We show that PGC1A controls the hepatic ratio of Insulin Receptor Substrates 1 (IRS1) and IRS2 expression, crucial for defining the precise insulin signal in hepatocytes to respond to fasting and feeding. Importantly, PGC1A is key for insulin-mediated suppression of hepatic glucose production.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Figures





Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The cited source says what the claim attributes to it.
In the citing paper
“Studies suggest that IRS1 and IRS2 have distinct roles in regulating hepatic lipid metabolism [20,30,97].”
From Hepatic Insulin Resistance and Steatosis in Metabolic Dysfunction-Associated Steatotic Liver Disease: New Insights into Mechanisms and Clinical Implications (2025) · cites this paper as [30]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Watterson, K. R., Bestow, D., Gallagher, J., Hamilton, D. L., Ashford, F. B., Meakin, P. J., & Ashford, M. L. J. (2013) · Neurosignals · doi:10.1159/000334144 · Cited by 3,389
Mechanisms of Insulin Action and Insulin Resistance
Petersen, M. C., & Shulman, G. I. (2018) · Physiological Reviews · doi:10.1152/physrev.00063.2017 · Cited by 3,028 · cited 1×
“In metabolic disorders such as type 2 diabetes and nonalcoholic fatty liver disease (NAFLD), the liver becomes resistant to the actions of insulin, even in a hyperinsulinemic context (3).”
BackgroundControl of hepatic gluconeogenesis through the transcriptional coactivator PGC-1
Yoon, J. C., Puigserver, P., Chen, G., Donovan, J., Wu, Z., Rhee, J., Adelmant, G., Stafford, J., Kahn, C. R., Granner, D. K., et al. (2001) · Nature · doi:10.1038/35093050 · Cited by 1,821 · cited 3×
“Moreover, PGC1A knockdown decreased basal and glucagon-induced G6pc and Pepck mRNA, as previously described (5), as well as Hsl, another PGC1A target (20) not regulated by glucagon (SI Appendix, Fig.”
BackgroundTranscriptional paradigms in mammalian mitochondrial biogenesis and function
Scarpulla, R. C. (2008) · Physiological Reviews · doi:10.1152/physrev.00025.2007 · Cited by 1,666 · cited 1×
“Peroxisome proliferator-activated receptor gamma coactivator 1-alpha (PGC1A) is a transcriptional coactivator within a family that includes two other members, peroxisome proliferatoractivated receptor gamma coactivator 1-beta (PGC1B) and peroxisome proliferator-activated receptor gamma coactivatorrelated protein 1 (PP…”
BackgroundmTOR controls mitochondrial oxidative function through a YY1–PGC-1α transcriptional complex
Cunningham, J. T., Rodgers, J. T., Arlow, D. H., Vazquez, F., Mootha, V. K., & Puigserver, P. (2007) · Nature · doi:10.1038/nature06322 · Cited by 1,488
CREB regulates hepatic gluconeogenesis through the coactivator PGC-1
Herzig, S., Long, F., Jhala, U. S., Hedrick, S., Quinn, R., Bauer, A., Rudolph, D., Schutz, G., Yoon, C., Puigserver, P., et al. (2001) · Nature · doi:10.1038/35093131 · Cited by 1,440 · cited 2×
“To determine whether TCF4 or CREB were necessary for the glucagon/PGC1A/IRS2 axis, we assessed the ability of glucagon and PGC1A to induce IRS2 in the presence of dominantnegative TCF4 (31) or CREB (21).”
BackgroundKoliaki, C., Szendroedi, J., Kaul, K., Jelenik, T., Nowotny, P., Jankowiak, F., Herder, C., Carstensen, M., Krausch, M., Knoefel, W. T., et al. (2015) · Cell Metabolism · doi:10.1016/j.cmet.2015.04.004 · Cited by 1,032
Leone, T. C., Lehman, J. J., Finck, B. N., Schaeffer, P. J., Wende, A. R., Boudina, S., Courtois, M., Wozniak, D. F., Sambandam, N., Bernal-Mizrachi, C., et al. (2005) · PLoS Biology · doi:10.1371/journal.pbio.0030101 · Cited by 951
Biochemical and cellular properties of insulin receptor signalling
Haeusler, R. A., McGraw, T. E., & Accili, D. (2018) · Nature Reviews Molecular Cell Biology · doi:10.1038/nrm.2017.89 · Cited by 739 · cited 2×
“Since various proteins can directly or indirectly regulate phosphorylation of AKT in response to insulin (2), we hypothesized that, as a transcriptional coactivator, PGC1A might differentially control expression of one or many of these intermediates.”
BackgroundLKB1 and AMP-activated protein kinase control of mTOR signalling and growth
Shaw, R. J. (2009) · Acta Physiologica · doi:10.1111/j.1748-1716.2009.01972.x · Cited by 644 · cited 1×
“Further studies are warranted to unravel mechanistic connections between PGC1A and mTOR, which could also be complicated by the effects of PGC1A on metabolites sensed by AMPK and mTOR (36).”
BackgroundPGC-1 promotes insulin resistance in liver through PPAR-α-dependent induction of TRB-3
Koo, S.-H., Satoh, H., Herzig, S., Lee, C.-H., Hedrick, S., Kulkarni, R., Evans, R. M., Olefsky, J., & Montminy, M. (2004) · Nature Medicine · doi:10.1038/nm1044 · Cited by 550
Ahrens, M., Ammerpohl, O., von Schönfels, W., Kolarova, J., Bens, S., Itzel, T., Teufel, A., Herrmann, A., Brosch, M., Hinrichsen, H., et al. (2013) · Cell Metabolism · doi:10.1016/j.cmet.2013.07.004 · Cited by 546
Dong, X. C., Copps, K. D., Guo, S., Li, Y., Kollipara, R., DePinho, R. A., & White, M. F. (2008) · Cell Metabolism · doi:10.1016/j.cmet.2008.06.006 · Cited by 463 · cited 1×
“Previous studies in IRS knockout mice (17, 18, 22, 40, 41) elegantly describe the requirement of the IRSs for whole-body energy metabolism during the fed-to-fasted transition, yet cell-autonomous effects on hepatic metabolic processes are still uncertain.”
BackgroundWesterbacka, J., Kolak, M., Kiviluoto, T., Arkkila, P., Sirén, J., Hamsten, A., Fisher, R. M., & Yki-Järvinen, H. (2007) · Diabetes · doi:10.2337/db07-0156 · Cited by 355
Regulation of Hepatic Glucose Uptake and Storage In Vivo
Moore, M. C., Coate, K. C., Winnick, J. J., An, Z., & Cherrington, A. D. (2012) · Advances in Nutrition · doi:10.3945/an.112.002089 · Cited by 354 · cited 1×
“High glucagon during fasting promotes glucose release from liver to provide a continuous source of fuel for peripheral tissues (1).”
BackgroundDevelopment of insulin resistance in mice lacking PGC-1α in adipose tissues
Kleiner, S., Mepani, R. J., Laznik, D., Ye, L., Jurczak, M. J., Jornayvaz, F. R., Estall, J. L., Chatterjee Bhowmick, D., Shulman, G. I., & Spiegelman, B. M. (2012) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1207287109 · Cited by 287
Self-citationWnt signaling regulates mitochondrial physiology and insulin sensitivity
Yoon, J. C., Ng, A., Kim, B. H., Bianco, A., Xavier, R. J., & Elledge, S. J. (2010) · Genes & Development · doi:10.1101/gad.1924910 · Cited by 257 · cited 1×
“T-Cell Factor 4 (TCF4/TCF7L2) regulates Irs1 expression (22, 23), binds to the Irs2 promoter (24), and is a major player in hepatic metabolic zonation, which also impacts IRS expression (22).”
BackgroundKubota, N., Kubota, T., Itoh, S., Kumagai, H., Kozono, H., Takamoto, I., Mineyama, T., Ogata, H., Tokuyama, K., Ohsugi, M., et al. (2008) · Cell Metabolism · doi:10.1016/j.cmet.2008.05.007 · Cited by 244 · cited 6×
“Previous studies in IRS knockout mice (17, 18, 22, 40, 41) elegantly describe the requirement of the IRSs for whole-body energy metabolism during the fed-to-fasted transition, yet cell-autonomous effects on hepatic metabolic processes are still uncertain.”
BackgroundResultInfluentialIrs1 and Irs2 signaling is essential for hepatic glucose homeostasis and systemic growth
Dong, X., Park, S., Lin, X., Copps, K., Yi, X., & White, M. F. (2006) · Journal of Clinical Investigation · doi:10.1172/jci25735 · Cited by 230 · cited 1×
“Previous studies in IRS knockout mice (17, 18, 22, 40, 41) elegantly describe the requirement of the IRSs for whole-body energy metabolism during the fed-to-fasted transition, yet cell-autonomous effects on hepatic metabolic processes are still uncertain.”
BackgroundRui, L., Fisher, T. L., Thomas, J., & White, M. F. (2001) · Journal of Biological Chemistry · doi:10.1074/jbc.m105332200 · Cited by 211 · cited 2×
“Interestingly, White and collaborators (34) show that, in a fed state (when PGC1A is low), IRS2 is degraded by a mTOR-dependent pathway.”
BackgroundSelective Chemical Inhibition of PGC-1α Gluconeogenic Activity Ameliorates Type 2 Diabetes
Sharabi, K., Lin, H., Tavares, C. D. J., Dominy, J. E., Camporez, J. P., Perry, R. J., Schilling, R., Rines, A. K., Lee, J., Hickey, M., et al. (2017) · Cell · doi:10.1016/j.cell.2017.03.001 · Cited by 210 · cited 1×
“While increased hepatic PGC1A levels are largely believed to negatively impact blood glucose control due to induction of enzymes that drive gluconeogenesis (5, 33), we show here that increased PGC1A in fasting liver also primes the liver to respond to insulin, counteracting uncontrolled glucose production.”
BackgroundMorris, E. M., Meers, G. M. E., Booth, F. W., Fritsche, K. L., Hardin, C. D., Thyfault, J. P., & Ibdah, J. A. (2012) · American Journal of Physiology-Gastrointestinal and Liver Physiology · doi:10.1152/ajpgi.00169.2012 · Cited by 186 · cited 1×
“Mouse models suggest that physiological reductions of PGC1A disrupt insulin signaling in liver (6, 7), and mice with low hepatic PGC1A are more susceptible to hepatic steatosis and hypertriglyceridemia, hallmarks of insulin resistance (6, 11, 12).”
BackgroundBesse-Patin, A., Léveillé, M., Oropeza, D., Nguyen, B. N., Prat, A., & Estall, J. L. (2017) · Gastroenterology · doi:10.1053/j.gastro.2016.09.017 · Cited by 176 · cited 20×
“Acute knockdown of PGC1B had no significant effect on these genes (SI Appendix, Fig.”
BackgroundInfluentialSelf-citationHepatic mTORC1 controls locomotor activity, body temperature, and lipid metabolism through FGF21
Cornu, M., Oppliger, W., Albert, V., Robitaille, A. M., Trapani, F., Quagliata, L., Fuhrer, T., Sauer, U., Terracciano, L., & Hall, M. N. (2014) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1412047111 · Cited by 152 · cited 1×
“Although we noted a positive correlation between Epas1 and Irs2, Epas1 (HIF2A) levels in liver increase postprandially to repress glucagon action (29), a time frame when PGC1A and IRS2 are at their lowest (17, 30).”
BackgroundGuo, S., Copps, K. D., Dong, X., Park, S., Cheng, Z., Pocai, A., Rossetti, L., Sajan, M., Farese, R. V., & White, M. F. (2009) · Molecular and Cellular Biology · doi:10.1128/mcb.00138-09 · Cited by 152 · cited 1×
“It has also been suggested that increased IRS1 might favor the lipogenic arm of insulin signaling (22, 37); thus, low PGC1A, which we show leads to a shift toward higher IRS1, might potentiate the production of lipids in response to insulin.”
BackgroundLouet, J.-F., Hayhurst, G., Gonzalez, F. J., Girard, J., & Decaux, J.-F. (2002) · Journal of Biological Chemistry · doi:10.1074/jbc.m205087200 · Cited by 150 · cited 2×
“Although we noted a positive correlation between Epas1 and Irs2, Epas1 (HIF2A) levels in liver increase postprandially to repress glucagon action (29), a time frame when PGC1A and IRS2 are at their lowest (17, 30).”
BackgroundEstall, J. L., Kahn, M., Cooper, M. P., Fisher, F. M., Wu, M. K., Laznik, D., Qu, L., Cohen, D. E., Shulman, G. I., & Spiegelman, B. M. (2009) · Diabetes · doi:10.2337/db08-1571 · Cited by 148 · cited 5×
“Primary mouse hepatocytes from 10- to 12-wk-old male and female mice were isolated by collagenase perfusion/percoll gradient purification and infected with adenoviruses as previously described (6).”
BackgroundMethodInfluentialSelf-citationPGC-1α regulates a HIF2α-dependent switch in skeletal muscle fiber types
Rasbach, K. A., Gupta, R. K., Ruas, J. L., Wu, J., Naseri, E., Estall, J. L., & Spiegelman, B. M. (2010) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1016089107 · Cited by 145
Self-citationKubota, N., Kubota, T., Kajiwara, E., Iwamura, T., Kumagai, H., Watanabe, T., Inoue, M., Takamoto, I., Sasako, T., Kumagai, K., et al. (2016) · Nature Communications · doi:10.1038/ncomms12977 · Cited by 143 · cited 4×
“T-Cell Factor 4 (TCF4/TCF7L2) regulates Irs1 expression (22, 23), binds to the Irs2 promoter (24), and is a major player in hepatic metabolic zonation, which also impacts IRS expression (22).”
BackgroundInfluentialZhang, W., Sargis, R. M., Volden, P. A., Carmean, C. M., Sun, X. J., & Brady, M. J. (2012) · PLoS ONE · doi:10.1371/journal.pone.0037103 · Cited by 118 · cited 1×
“2% BSA and 1 mM glutamine, with no glucose, red phenol or NaPyruvate) for 1 h to induce glycogenolysis and deplete glycogen (44).”
BackgroundSczelecki, S., Besse-Patin, A., Abboud, A., Kleiner, S., Laznik-Bogoslavski, D., Wrann, C. D., Ruas, J. L., Haibe-Kains, B., & Estall, J. L. (2014) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.00578.2013 · Cited by 108
Self-citationSelective insulin resistance with differential expressions of IRS-1 and IRS-2 in human NAFLD livers
Honma, M., Sawada, S., Ueno, Y., Murakami, K., Yamada, T., Gao, J., Kodama, S., Izumi, T., Takahashi, K., Tsukita, S., et al. (2018) · International Journal of Obesity · doi:10.1038/s41366-018-0062-9 · Cited by 108 · cited 1×
“Livers of type 2 diabetic and NAFLD patients are shown to have decreased PGC1A (8–10), correlating with low IRS2 and high IRS1 expression (22, 38).”
BackgroundBlättler, S. M., Cunningham, J. T., Verdeguer, F., Chim, H., Haas, W., Liu, H., Romanino, K., Rüegg, M. A., Gygi, S. P., Shi, Y., et al. (2012) · Cell Metabolism · doi:10.1016/j.cmet.2012.03.008 · Cited by 105 · cited 1×
“Yin Yang 1 (YY1) and Hypoxia Inducible Factor 2A (HIF2A/Epas1) bind PGC1A (25, 26) and can also regulate IRS gene transcription (27, 28).”
BackgroundA liver Hif-2α–Irs2 pathway sensitizes hepatic insulin signaling and is modulated by Vegf inhibition
Wei, K., Piecewicz, S. M., McGinnis, L. M., Taniguchi, C. M., Wiegand, S. J., Anderson, K., Chan, C. W.-M., Mulligan, K. X., Kuo, D., Yuan, J., et al. (2013) · Nature Medicine · doi:10.1038/nm.3295 · Cited by 101 · cited 1×
“Yin Yang 1 (YY1) and Hypoxia Inducible Factor 2A (HIF2A/Epas1) bind PGC1A (25, 26) and can also regulate IRS gene transcription (27, 28).”
BackgroundNorton, L., Fourcaudot, M. J., Abdul-Ghani, M. A., Winnier, D. A., Mehta, F. F., Jenkinson, C. P., & DeFronzo, R. A. (2011) · Diabetologia · doi:10.1007/s00125-011-2289-z · Cited by 94 · cited 1×
“T-Cell Factor 4 (TCF4/TCF7L2) regulates Irs1 expression (22, 23), binds to the Irs2 promoter (24), and is a major player in hepatic metabolic zonation, which also impacts IRS expression (22).”
BackgroundSerine Phosphorylation by mTORC1 Promotes IRS-1 Degradation through SCFβ-TRCP E3 Ubiquitin Ligase
Yoneyama, Y., Inamitsu, T., Chida, K., Iemura, S.-I., Natsume, T., Maeda, T., Hakuno, F., & Takahashi, S.-I. (2018) · iScience · doi:10.1016/j.isci.2018.06.006 · Cited by 85 · cited 1×
“Research shows that mTOR activity primarily affects the phosphorylation status of IRS1 and IRS2, not its expression level (34, 35).”
BackgroundDual role of the coactivator TORC2 in modulating hepatic glucose output and insulin signaling
Canettieri, G., Koo, S., Berdeaux, R., Heredia, J., Hedrick, S. A., Zhang, X., & Montminy, M. (2005) · Cell Metabolism · doi:10.1016/j.cmet.2005.09.008 · Cited by 74 · cited 5×
“Previous studies in IRS knockout mice (17, 18, 22, 40, 41) elegantly describe the requirement of the IRSs for whole-body energy metabolism during the fed-to-fasted transition, yet cell-autonomous effects on hepatic metabolic processes are still uncertain.”
BackgroundInfluentialOropeza, D., Jouvet, N., Bouyakdan, K., Perron, G., Ringuette, L., Philipson, L. H., Kiss, R. S., Poitout, V., Alquier, T., & Estall, J. L. (2015) · Molecular Metabolism · doi:10.1016/j.molmet.2015.08.001 · Cited by 68 · cited 1×
“Moreover, PGC1A knockdown decreased basal and glucagon-induced G6pc and Pepck mRNA, as previously described (5), as well as Hsl, another PGC1A target (20) not regulated by glucagon (SI Appendix, Fig.”
BackgroundSelf-citationHepatic Glucagon Receptor Signaling Enhances Insulin-Stimulated Glucose Disposal in Rodents
Kim, T., Holleman, C. L., Nason, S., Arble, D. M., Ottaway, N., Chabenne, J., Loyd, C., Kim, J.-A., Sandoval, D., Drucker, D. J., et al. (2018) · Diabetes · doi:10.2337/db18-0068 · Cited by 68 · cited 1×
“Our data illustrating the importance of the PGC1A/CREB/IRS2 axis downstream of glucagon are in line with a recent paper elegantly showing that glucagon signaling is required for the finely tuned actions of insulin in liver during fasting and feeding (32).”
ResultRabiee, A., Krüger, M., Ardenkjær-Larsen, J., Kahn, C. R., & Emanuelli, B. (2018) · Cellular Signalling · doi:10.1016/j.cellsig.2018.03.003 · Cited by 62 · cited 1×
“A recent study in brown adipose tissue shows that overexpression of IRS1 or IRS2 has broad and distinctive signaling outcomes (39).”
BackgroundIp, W., Shao, W., Song, Z., Chen, Z., Wheeler, M. B., & Jin, T. (2015) · Diabetes · doi:10.2337/db14-1329 · Cited by 61 · cited 7×
“Vectors were kindly provided by Drs. S. Guo (IRS1 and IRS2), L. Alonso (shIRS2), M. Montminy (CREB DN), B. Spiegelman (PGC-1B), and T. Jin (TCF4 DN).”
BackgroundInfluentialRamakrishnan, S. K., Zhang, H., Takahashi, S., Centofanti, B., Periyasamy, S., Weisz, K., Chen, Z., Uhler, M. D., Rui, L., Gonzalez, F. J., et al. (2016) · Cell Metabolism · doi:10.1016/j.cmet.2016.01.004 · Cited by 51 · cited 1×
“Although we noted a positive correlation between Epas1 and Irs2, Epas1 (HIF2A) levels in liver increase postprandially to repress glucagon action (29), a time frame when PGC1A and IRS2 are at their lowest (17, 30).”
BackgroundChambers, K. T., Chen, Z., Crawford, P. A., Fu, X., Burgess, S. C., Lai, L., Leone, T. C., Kelly, D. P., & Finck, B. N. (2012) · PLoS ONE · doi:10.1371/journal.pone.0052645 · Cited by 42 · cited 1×
“Importantly, PGC1B is thought to play a more significant role in lipogenesis (43).”
BackgroundChambers, K. T., Chen, Z., Lai, L., Leone, T. C., Towle, H. C., Kralli, A., Crawford, P. A., & Finck, B. N. (2013) · Molecular Metabolism · doi:10.1016/j.molmet.2013.05.001 · Cited by 36 · cited 1×
“This highlights an important functional distinction between these structurally related coactivators, which share many downstream targets but seem to also have unique roles in liver surrounding glucose and lipid metabolism (42).”
BackgroundJavary, J., Allain, N., Saucisse, N., Costet, P., Héraud, C., Benhamed, F., Pierre, R., Buré, C., Pallares‐Lupon, N., Cruzeiro, M. D., et al. (2017) · Gut · doi:10.1136/gutjnl-2017-314208 · Cited by 30 · cited 1×
“2) were likely due to indirect feedback on this arm of the pathway, as seen previously (16), and not due to direct coactivation by the PGC-1s.”
BackgroundPopescu, I. R., Mussman, G. M., HUGHES, C. B., JANES, T. J., Ray, P., Bunn, R. C., Fowlkes, J. L., & Thrailkill, K. M. (2018) · Diabetes · doi:10.2337/db18-2157-p · Cited by 5
Cited by
PGC-1 α, Inflammation, and Oxidative Stress: An Integrative View in Metabolism
Rius-Pérez, S., Torres-Cuevas, I., Millán, I., Ortega, Á. L., & Pérez, S. (2020) · Oxidative Medicine and Cellular Longevity · doi:10.1155/2020/1452696 · Cited by 642
“Indeed mice with liverspecific mutations in the insulin receptor present high PGC-1α levels in the liver, which demonstrates the key role of insulin as a suppressor of PGC-1α [45, 49].”
BackgroundMechanisms of muscle insulin resistance and the cross‐talk with liver and adipose tissue
Silva Rosa, S. C., Nayak, N., Caymo, A. M., & Gordon, J. W. (2020) · Physiological Reports · doi:10.14814/phy2.14607 · Cited by 240
Molecular Mechanisms of Glucocorticoid-Induced Insulin Resistance
Beaupere, C., Liboz, A., Fève, B., Blondeau, B., & Guillemain, G. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms22020623 · Cited by 271
Insulin action at a molecular level – 100 years of progress
White, M. F., & Kahn, C. R. (2021) · Molecular Metabolism · doi:10.1016/j.molmet.2021.101304 · Cited by 212
“Fasting and exercise also induce the CREB CRTC2 transcriptional complex through glucagon signaling; this increases expression of gluconeogenic genes as well as IRS2 [129].”
BackgroundInfluentialSingh, A., Shadangi, S., Gupta, P. K., & Rana, S. (2025) · Comprehensive Physiology · doi:10.1002/cph4.70003 · Cited by 163
Metadata
- Authors
- Besse-Patin, A., Jeromson, S., Levesque-Damphousse, P., Secco, B., Laplante, M., & Estall, J. L.
- Affiliations
- Institut de Recherches Cliniques de Montréal (IRCM), Montreal, QC, Canada H2W 1R7;
- Montreal Clinical Research Institute (CA)
- Institut universitaire de cardiologie et de pneumologie de Québec (CA)
- Corresponding author
- Estall, Jennifer L.
- Venue
- Proceedings of the National Academy of Sciences
- Publisher
- National Academy of Sciences
- Published
- 2019-02-15
- Volume
- 116
- Issue
- 10
- Pages
- 4285-4290
- ISSN
- 0027-8424 (ISSN-L)
- 1091-6490
- PMC
- PMC6410797
- OpenAlex
- W2913974217
- Cited by
- 124
- References
- 46
- Citations by year
- 2026: 9 · 2025: 20 · 2024: 20 · 2023: 17 · 2022: 12 · 2021: 21 · 2020: 22 · 2019: 3
- FWCI
- 4.80
- Type
- journal article
- Language
- en
- Open access
- hybrid
- doi.org
- Licence
- Locations
- Proceedings of the National Academy of Sciences (publishedVersion, cc-by-nc-nd)
- Europe PMC (PubMed Central) (publishedVersion, cc-by-nc-nd)
- PubMed Central (publishedVersion, cc-by-nc-nd)
- PubMed (publishedVersion)
- Funders
- Gouvernement du Canada | Canadian Institutes of Health Research (SVB-145591)
- Fonds de Recherche du Québec - Santé (35208)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Metabolism, Diabetes, and Cancer
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Peroxisome Proliferator-Activated Receptors
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Pancreatic function and diabetes
- Keywords
- PGC-1α, IRS-1, insulin receptor substrate 2, insulin signaling, hepatic gluconeogenesis, fasting, glucagon signaling, CREB, Akt, glucose homeostasis, insulin resistance, hepatocytes, non-alcoholic fatty liver disease, type 2 diabetes, cyclic AMP
- MeSH terms
- Peroxisome Proliferator-Activated Receptor Gamma Coactivator 1-alpha, Animals, Diabetes Mellitus, Type 2, Fasting, Female, Gene Expression Regulation, Glucagon, Gluconeogenesis, Glucose, Homeostasis, Humans, Insulin, Insulin Resistance, Liver, Liver Diseases, Male, Signal Transduction, Cyclic AMP Response Element-Binding Protein, Hepatocytes, Models, Animal, Proto-Oncogene Proteins c-akt, Mice, Insulin Receptor Substrate Proteins
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.